• Leading Cell & Gene Therapy CRO/CDMO
    Gene editing & stem cell technology platforms to advance your immunotherapy, disease modeling, or bioproduction.
    • 15 off-the-shelf iPSC-derived products (NPCs, HPCs) and ready-to-use GMP iPSCs for cell therapy
    • Monoclonal antibody development & in vivo efficacy services with 2,000+ mouse models
    • Unique IP landscape, over 1,000 projects completed, and clients in 47 countries

Home Page

Customizable Services


Number of Clients


Completed Projects




Years of Experience
ISO 13485 & GMP Ready      NIST Genome Editing Consortium Member

News & Events

Aug 29, 2022

Applied StemCell Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy

Milpitas, California, August 29, 2022 -- Applied StemCell, Inc. (ASC), a leading cell and gene therapy CRO/CDMO focused on supporting the research community and biotechnology industry for their needs in developing and manufacturing cell and gene products, today announced...

Read more

Click for more news!